Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep;85(5):721–726. doi: 10.1054/bjoc.2001.1990

TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

P Tanière 1,2, G Martel-Planche 1, J C Saurin 3, C Lombard-Bohas 3, F Berger 2, J Y Scoazec 2, P Hainaut 1
PMCID: PMC2364124  PMID: 11531258

Abstract

In Europe, high incidence rates of oesophageal squamous cell carcinoma (SCCE) are observed in western France (Normandy and Brittany) and in north-eastern Italy. Analysis of TP53 mutations in tumours from these regions has shown a high prevalence of mutations at A:T basepairs that may result from DNA damage caused by specific mutagens. However, the spectrum of TP53 mutations in regions of low incidence is unknown. We report here TP53 mutation analysis in 33 SCCE collected in Lyon, an area of low incidence. These tumours were also examined for MDM2 and P63 amplification, and for expression of p16INK4a/CDKN2a, cyclin E, p27Kipland Cox2. TP53 mutations were detected in 36% of the cases (12/33). In contrast with regions of high incidence, the mutation spectrum did not show a high prevalence of mutations at A:T base pairs. P63 was amplified in 5/32 cases tested (15.5%). No amplification of MDM2 was found. Expression studies revealed frequent loss of p16INK4a/CDKN2a(46%) and p27Kipl(25%) expression, and frequent overexpression of Cyclin E (70%) and Cox2 (42%). Overall, these results indicate that in Europe, SCCE from areas of high and low incidence present a similar pattern of molecular alterations but differ by the type of TP53 mutations. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: oesophagus, squamous cell carcinoma, low-incidence area, TP53, P63, MDM2

Full Text

The Full Text of this article is available as a PDF (117.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal S., Taneja N., Lin L., Orringer M. B., Rehemtulla A., Beer D. G. Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression. Neoplasia. 2000 Jul-Aug;2(4):346–356. doi: 10.1038/sj.neo.7900097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anayama T., Furihata M., Ishikawa T., Ohtsuki Y., Ogoshi S. Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer. 1998 Aug 21;79(4):439–443. doi: 10.1002/(sici)1097-0215(19980821)79:4<439::aid-ijc22>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  3. Audrézet M. P., Robaszkiewicz M., Mercier B., Nousbaum J. B., Bail J. P., Hardy E., Volant A., Lozac'h P., Charles J. F., Gouéron H. TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res. 1993 Dec 1;53(23):5745–5749. [PubMed] [Google Scholar]
  4. Barnas C., Martel-Planche G., Furukawa Y., Hollstein M., Montesano R., Hainaut P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer. 1997 Mar 28;71(1):79–87. doi: 10.1002/(sici)1097-0215(19970328)71:1<79::aid-ijc14>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  5. Biernat W., Kleihues P., Yonekawa Y., Ohgaki H. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol. 1997 Feb;56(2):180–185. doi: 10.1097/00005072-199702000-00009. [DOI] [PubMed] [Google Scholar]
  6. Esteve A., Lehman T., Jiang W., Weinstein I. B., Harris C. C., Ruol A., Peracchia A., Montesano R., Hollstein M. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog. 1993;8(4):306–311. doi: 10.1002/mc.2940080414. [DOI] [PubMed] [Google Scholar]
  7. Fujii S., Tominaga O., Nagawa H., Tsuno N., Nita M. E., Tsuruo T., Muto T. Quantitative analysis of the cyclin expression in human esophageal cancer cell lines. J Exp Clin Cancer Res. 1998 Dec;17(4):491–496. [PubMed] [Google Scholar]
  8. Hibi K., Trink B., Patturajan M., Westra W. H., Caballero O. L., Hill D. E., Ratovitski E. A., Jen J., Sidransky D. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5462–5467. doi: 10.1073/pnas.97.10.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hollstein M. C., Peri L., Mandard A. M., Welsh J. A., Montesano R., Metcalf R. A., Bak M., Harris C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res. 1991 Aug 1;51(15):4102–4106. [PubMed] [Google Scholar]
  10. Itami A., Shimada Y., Watanabe G., Imamura M. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology. 1999 Nov;57(4):311–317. doi: 10.1159/000012067. [DOI] [PubMed] [Google Scholar]
  11. Launoy G., Faivre J., Pienkowski P., Milan C., Gignoux M., Pottier D. Changing pattern of oesophageal cancer incidence in France. Int J Epidemiol. 1994 Apr;23(2):246–251. doi: 10.1093/ije/23.2.246. [DOI] [PubMed] [Google Scholar]
  12. Launoy G., Milan C. H., Faivre J., Pienkowski P., Milan C. I., Gignoux M. Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer. 1997;75(9):1389–1396. doi: 10.1038/bjc.1997.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Launoy G., Milan C., Faivre J., Pienkowski P., Gignoux M. Tobacco type and risk of squamous cell cancer of the oesophagus in males: a French multicentre case-control study. Int J Epidemiol. 2000 Feb;29(1):36–42. doi: 10.1093/ije/29.1.36. [DOI] [PubMed] [Google Scholar]
  14. Li M., Lotan R., Levin B., Tahara E., Lippman S. M., Xu X. C. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):545–549. [PubMed] [Google Scholar]
  15. Mandard A. M., Hainaut P., Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res. 2000 Apr;462(2-3):335–342. doi: 10.1016/s1383-5742(00)00019-3. [DOI] [PubMed] [Google Scholar]
  16. Momand J., Jung D., Wilczynski S., Niland J. The MDM2 gene amplification database. Nucleic Acids Res. 1998 Aug 1;26(15):3453–3459. doi: 10.1093/nar/26.15.3453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Muto M., Hitomi Y., Ohtsu A., Ebihara S., Yoshida S., Esumi H. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut. 2000 Aug;47(2):256–261. doi: 10.1136/gut.47.2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Muto M., Hitomi Y., Ohtsu A., Shimada H., Kashiwase Y., Sasaki H., Yoshida S., Esumi H. Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer. 2000 Nov 1;88(3):342–350. [PubMed] [Google Scholar]
  19. Ohashi Y., Sasano H., Yamaki H., Shizawa S., Shineha R., Akaishi T., Satomi S., Nagura H. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Anticancer Res. 1999 May-Jun;19(3A):1843–1848. [PubMed] [Google Scholar]
  20. Parsa R., Yang A., McKeon F., Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol. 1999 Dec;113(6):1099–1105. doi: 10.1046/j.1523-1747.1999.00780.x. [DOI] [PubMed] [Google Scholar]
  21. Pisani P., Parkin D. M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999 Sep 24;83(1):18–29. doi: 10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  22. Robert V., Michel P., Flaman J. M., Chiron A., Martin C., Charbonnier F., Paillot B., Frebourg T. High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis. 2000 Apr;21(4):563–565. doi: 10.1093/carcin/21.4.563. [DOI] [PubMed] [Google Scholar]
  23. Shamma A., Doki Y., Tsujinaka T., Shiozaki H., Inoue M., Yano M., Kawanishi K., Monden M. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology. 2000 Feb;58(2):152–158. doi: 10.1159/000012092. [DOI] [PubMed] [Google Scholar]
  24. Shirvani V. N., Ouatu-Lascar R., Kaur B. S., Omary M. B., Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology. 2000 Mar;118(3):487–496. doi: 10.1016/s0016-5085(00)70254-x. [DOI] [PubMed] [Google Scholar]
  25. Tanière P., Martel-Planche G., Maurici D., Lombard-Bohas C., Scoazec J. Y., Montesano R., Berger F., Hainaut P. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol. 2001 Jan;158(1):33–40. doi: 10.1016/S0002-9440(10)63941-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tanière P., Martel-Planche G., Puttawibul P., Casson A., Montesano R., Chanvitan A., Hainaut P. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand. Int J Cancer. 2000 Oct 15;88(2):223–227. doi: 10.1002/1097-0215(20001015)88:2<223::aid-ijc12>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  27. Wang Q. S., Sabourin C. L., Wang H., Stoner G. D. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis. 1996 Aug;17(8):1583–1588. doi: 10.1093/carcin/17.8.1583. [DOI] [PubMed] [Google Scholar]
  28. Yamaguchi K., Wu L., Caballero O. L., Hibi K., Trink B., Resto V., Cairns P., Okami K., Koch W. M., Sidransky D. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer. 2000 Jun 1;86(5):684–689. doi: 10.1002/(sici)1097-0215(20000601)86:5<684::aid-ijc13>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  29. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M. D., Dötsch V., Andrews N. C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998 Sep;2(3):305–316. doi: 10.1016/s1097-2765(00)80275-0. [DOI] [PubMed] [Google Scholar]
  30. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R. T., Tabin C., Sharpe A., Caput D., Crum C. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999 Apr 22;398(6729):714–718. doi: 10.1038/19539. [DOI] [PubMed] [Google Scholar]
  31. Zambon P., Talamini R., La Vecchia C., Dal Maso L., Negri E., Tognazzo S., Simonato L., Franceschi S. Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. Int J Cancer. 2000 Apr 1;86(1):144–149. doi: 10.1002/(sici)1097-0215(20000401)86:1<144::aid-ijc23>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES